Mader R, Gladman DD, Long J, Gough J, Farewell VT: Does injectable gold retard radiologic evidence of joint damage in psoriatic arthritis. Clinical Investigative Medicine 18:139-143, 1995.

Abu-Shakra M, Gladman DD, Thorne JC, Long J, Gough J, Farewell VT: Longterm Methotrexate therapy in Psoriatic Arthritis: Clinical and radiologic outcome. J Rheumatol 22:241-245, 1995.

Gladman DD, Farewell VT, Nadeau C: Clinical indicators of progression in psoriatic arthritis (PSA): multivariate relative risk model. J Rheumatol 22:675-679, 1995.

Blackmore M, Gladman DD, Husted J, Long J, Farewell VT: Measuring Health Status in Psoriatic Arthritis: The Health Assessment Questionnaire and its modification. J Rheumatol 22:886-893, 1995.

Kovacs JAJ, Urowitz MB, Gladman DD, Zeman R: Single Photon Emission Computerized Tomography (SPECT) in neuropsychiatric SLE (NPSLE). J Rheumatol 22:1347-1253, 1995

Abu-Shakra M, Urowitz MB, Gladman DD, Gough J: Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death. J Rheumatol 22:1259-1264, 1995

Abu-Shakra M, Urowitz MB, Gladman DD, Gough J: Mortality studies in systemic lupus erythematosus. Results from a single centre. II. Predictor variables for mortality. J Rheumatol 22:1265-1270, 1995

Pruzanski W, Urowitz MB, Groulx B, Vadas: Induction of TNFa and Proinflammatory Secretory Phospholipase A2 By Intravenous Administration of CAMPATH 1H in Rheumatoid Arthritis J Rheumatol 22(10):1816-819, 1995

Urowitz MB: Premature Senescence and Burden of Life – Lessons from the Rheumatic Diseases. (Editorial) J Rheumatol 22(6):1007-1008, 1995.

Weinblatt ME, Maddison PJ, Bulpitt KJ, Hazleman BL, Urowitz MB, Sturrock RD, Coblyn JS, Maier AL, Spreen WR, Manna VK, Johnston JM: Campath-1H, A Humanized Monoclonal Antibody, in Refractory Rheumatoid Arthritis. An Intravenous Dose-Escalated Study Arthritis Rheum 38:(11): 1589-1594, 1995.

Mahood J, Bogoch E, Gladman DD, MacDonald J, Urowitz MB, Goldsmith CH: Osteonecrosis of the Hip: A new validated method of assessing femoral head involvement. J Orthopedic Rheumatology 8:37-42, 1995

Gladman DD, Farewell VT: The role of HLA antigens as indicators of progression in psoriatic arthritis (PSA): multivariate relative risk model. Arthritis Rheum 38:845-850, 1995

Husted J, Gladman DD, Farewell V, Long J: Modified HAQ in psoriatic arthritis. Clin Exp Rheumatol 13:439-444, 1995

Abu-Shakra M, Gladman DD, Urowitz MB, Farewell VT: Anticardiolipin antibodies in systemic lupus erythematosus: Clinical and laboratory correlations. Am J Med 99:624-628, 1995.

Abu-Shakra M, Gladman D, Sukenik S: Systemic Lupus Erythematosus. J Isr Med Assoc (Harefuah) 129:358-361, 1995.

Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, Isenberg D, Jones J, Nived O, Petri M, Richter M, Sanchez-Guerrero J, Snaith M, Sturfelt G, Symmons D: The development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum 39:363-369, 1996.

Abu-Shakra M, Urowitz MB, Gladman DD, Ritchie S: The significance of anticardiolipin antibodies in patients with lupus nephritis. Lupus 5:70-73, 1996.

Urowitz MB: Rheumatology in the 90s: Managing the coming crisis. J Can Rheum Ass 6:3, 1996.

Urowitz MB: Canadian Rheumatology Manpower: Is it time to cry wolf? J Can Rheum Ass 6:4-6, 1996.

Husted J, Gladman DD, Farewell VT, Long J: Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with Psoriatic Arthritis. J Rheumatol 23:1015-1019, 1996.

Abu-Shakra M, Gladman DD, Urowitz MB: Malignancy in SLE. Arthritis Rheum 39:1050-1054, 1996.

Gladman D, Urowitz M, Ong A, Gough J: A comparison of five Health Status Instruments in Patients with Systemic Lupus Erythematosus (SLE). Lupus 5:190-195, 1996.

Gladman D, Urowitz M, Ong A, Gough J, MacKinnon A: Lack of Correlation among 3 outcome measures in SLE: Disease Activity, damage and quality of life. Clin Exp Rheumatol 14:305-308,1996.

Gladman DD, Urowitz M, Fortin P, Isenberg D, Petri M, Goldsmith C, Gordon C, et al: Workshop Report: Systemic Lupus Erythematosus International Collaborating Clinics(SLICC) Conference on Assessment of Lupus Flare and Quality of Life Measures in SLE. J Rheumatol 23:1953-1955,1996.

Husted J, Gladman DD, Long JA, Farewell VT: Relationship of the Arthritis Impact Measurements Scales (AIMS) to changes in articular status and functional performance in patients with psoriatic arthritis (PsA). J Rheumatol 23: 1932-1937, 1996

Koh ET, Lee P, Gladman DD, Abu-Shakra M: Pulmonary hypertension in systemic sclerosis: an analysis of 18 patients. Brit J Rheumatology 35:989-993, 1996

Husted J Gladman DD, Long JA, Farewell VT, Cook R: Validating the SF-36 health questionnaire in patients with Psoriatic Arthritis. J Rheumatology 24:511-517, 1997.

Gladman D, Urowitz MB, Goldsmith C, Fortin P, Ginzler E, Gordon C, Hanly J, Isenberg D, Kalunian K, Nived O, Petri P, Sanchez-Guerrero J, Snaith M, Sturfelt G: Assessment of the reliability of the SLICC/ACR damage index for SLE. Arthritis Rheum Arthritis Rheum 40:809-813, 1997

Urowitz MB, Abu-Shakra M, Gladman DD, Gough J, Farewell VT: Mortality studies in systemic lupus erythematosus.Results from a single center. III. Improved survival in SLE. J Rheumatol 24:1061-1065, 1997.

Cook RJ, Farewell VT, Gladman DD: Methodology for clinical trials in rheumatology: A logical foundation. J Rheumatol 24:1861-1865, 1997

Wong K, Gladman DD, Husted J, Long J, Farewell VT: Mortality studies in psoriatic arthritis. Results from a single centre. I. Risk and Causes of Death. Arthritis Rheum　 40:1873-1877, 1997

Gladman D, Urowitz M, Gough J, MacKinnon A: Fibromyalgia is a major contributor to quality of life in lupus. J Rheumatol 24:2145-2149, 1997

Kreidstein SH, Urowitz MB, Gladman DD, Gough JM: Hormone replacement therapy in SLE. J Rheumatol 24:2149-2152, 1997

Glanz B, Slonim D, Urowitz MB, Gladman DD, Gough JG, MacKinnon A: Patterns of Neuropsychological dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry, Neuropsychology and Behavioral Neurology 10(4):232-238, 1997

Rahman P, Urowitz MB, Gladman DD: Cytotoxic therapy in systemic lupus erythematosus: experience from a single centre. Medicine (In press).

Rahman P, Humphrey-Murto, S. Gladman DD, Urowitz MB: Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis. J Rheumatol (In press)

Bruce I, Gladman DD: Psoriatic arthritis. Recognition and management. BioDrugs
(In press)

Gladman DD, Farewell VT, Kopciuk K, Cook RJ: HLA Antigens and Progression in Psoriatic Arthritis J Rheumatol (In press)

Back to Publications